Cognitive-driven ADL Impairment as a Predictor for PDD

Exclusion Criteria

• •Any disability that may prevent the subject from completing the informed consent form or other study requirements.
• •Other neurodegenerative disease which renders the subject unable to communicate well with the investigator or to understand and comply with the requirements of the study.
• •Participation in any clinical investigation of a new investigational compound or therapy within 4 weeks prior to baseline visit, and for any other limitation of participation based on local regulations.
• •Alcohol, medication or drug dependency or abuse (except for nicotine).
• •History of brain disease other than PD, e.g. head trauma, stroke, encephalitis, etc.